CSIMarket
 


Vir Biotechnology Inc   (VIR)
Other Ticker:  
 

Vir Biotechnology Inc 's Total Debt to Equity

VIR's quarterly Total Debt to Equity and Total Debt, Equity growth




VIR Total Debt to Equity (Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Equity Change 145.34 % 164.74 % 207.4 % 99.74 % 7.87 %
Y / Y Total Debt Change - - - - -
Total Debt to Equity MRQ - - - - -
Overall Ranking Seq. Equity Change 10.14 % -2.45 % 39.75 % 63.4 % 18.85 %
Seq. Total Debt Change - - - - -



Total Debt to Equity third quarter 2022 Comment
In the third quarter 2022 Vir Biotechnology Inc did not have Total Debt .

Within Biotechnology & Pharmaceuticals industry Vir Biotechnology Inc achieved lowest Total Debt to Equity. While total ranking remained unchanged compare to previous quarter at no. .

Explain Debt to Equity Ratio?
Where is VIR most successful ?
Total Debt to Equity VIR on the trailing twelve month basis
Total Debt to Equity third quarter 2022 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall Market #


Total Debt to Equity Statistics
High Average Low
0 0 0
 




Financial Statements
Vir Biotechnology Inc 's Equity $ 2,150 Millions Visit VIR's Balance sheet
Vir Biotechnology Inc 's Total Debt $ 0 Millions Visit VIR's Balance sheet
Source of VIR's Sales Visit VIR's Sales by Geography


Cumulative Vir Biotechnology Inc 's Total Debt to Equity

VIR's Total Debt to Equity for the trailling 12 Months

VIR Total Debt to Equity

(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Equity TTM Growth 145.34 % 164.74 % 207.4 % 99.74 % 7.87 %
Y / Y Total Debt TTM Growth - - - - -
Total Debt to Equity TTM - - - - -
Total Ranking TTM Seq. Equity TTM Growth 10.14 % -2.45 % 39.75 % 63.4 % 18.85 %
Seq. Total Debt TTM Growth - - - - -


TTM Total Debt to Equity Comment
On the trailing twelve months basis In the III. Quarter Vir Biotechnology Inc did not have Total Debt .
Total Debt to Equity is the average cumulative value over the last four quarters.

Among companies in the Biotechnology & Pharmaceuticals industry VIR recorded the lowest Total Debt to Equity. While total ranking remained unchanged compare to previous quarter at no. 0.

Explain Debt to Equity Ratio?
Where is VIR most successful ?
Total Debt to Equity VIR on the trailing twelve month basis

TTM Total Debt to Equity Company Ranking
Within: No.
Within the Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Within the Market #


TTM Total Debt to Equity Statistics
High Average Low
0 0 0
 




Companies with similar Total Debt to Equity in the quarter ending Sep 30 2022, within Biotechnology & Pharmaceuticals Industry Total Debt to EquitySep 30 2022 MRQ Total DebtSep 30 2022 MRQ Equity

Date modified: 2022-11-06T04:16:49+00:00

Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

GSQB's Profile

Stock Price

GSQB's Financials

Business Description

Fundamentals

Charts & Quotes

GSQB's News

Suppliers

GSQB's Competitors

Customers & Markets

Economic Indicators

GSQB's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071